Stereotaxis Inc
NYSE-MKT:STXS
Intrinsic Value
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary arter... [ Read More ]
The intrinsic value of one STXS stock under the Base Case scenario is 2.95 USD. Compared to the current market price of 2.18 USD, Stereotaxis Inc is Undervalued by 26%.
Valuation Backtest
Stereotaxis Inc
Run backtest to discover the historical profit from buying and selling STXS stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Stereotaxis Inc
Current Assets | 33.3m |
Cash & Short-Term Investments | 19.8m |
Receivables | 3.8m |
Other Current Assets | 9.6m |
Non-Current Assets | 8.6m |
PP&E | 8.3m |
Other Non-Current Assets | 356k |
Current Liabilities | 13.2m |
Accounts Payable | 3.2m |
Accrued Liabilities | 2.4m |
Other Current Liabilities | 7.7m |
Non-Current Liabilities | 6.7m |
Other Non-Current Liabilities | 6.7m |
Earnings Waterfall
Stereotaxis Inc
Revenue
|
26.8m
USD
|
Cost of Revenue
|
-11.9m
USD
|
Gross Profit
|
14.9m
USD
|
Operating Expenses
|
-36.7m
USD
|
Operating Income
|
-21.8m
USD
|
Other Expenses
|
-217k
USD
|
Net Income
|
-22.1m
USD
|
Free Cash Flow Analysis
Stereotaxis Inc
STXS Profitability Score
Profitability Due Diligence
Stereotaxis Inc's profitability score is 22/100. The higher the profitability score, the more profitable the company is.
Score
Stereotaxis Inc's profitability score is 22/100. The higher the profitability score, the more profitable the company is.
STXS Solvency Score
Solvency Due Diligence
Stereotaxis Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.
Score
Stereotaxis Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
STXS Price Targets Summary
Stereotaxis Inc
According to Wall Street analysts, the average 1-year price target for STXS is 4.69 USD with a low forecast of 4.04 USD and a high forecast of 5.25 USD.
Ownership
STXS Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
STXS Price
Stereotaxis Inc
Average Annual Return | 32.2% |
Standard Deviation of Annual Returns | 101.51% |
Max Drawdown | -86% |
Market Capitalization | 176.5m USD |
Shares Outstanding | 82 128 800 |
Percentage of Shares Shorted | 1.39% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. The company is headquartered in St. Louis, Missouri and currently employs 130 full-time employees. The company went IPO on 2004-08-12. The firm's robotic technology, Robotic Magnetic Navigation, fundamentally transforms endovascular interventions using computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. Its primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. The firm also offers to its customers the Stereotaxis Imaging Model S X-ray System and other accessory devices. The Genesis RMN System is designed to enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites. The Odyssey Solution consolidates lab information onto an integrated display, enabling physicians to view and control all the key information in the operating room.
Contact
IPO
Employees
Officers
The intrinsic value of one STXS stock under the Base Case scenario is 2.95 USD.
Compared to the current market price of 2.18 USD, Stereotaxis Inc is Undervalued by 26%.